Restrictive Coverage Policies and Patient Access

Please read this timely article by Mark Ballow, M.D. published in Healthcare Payer News. Dr. Ballow addresses restrictive coverage policies that have a negative impact on patient access and patient care; particularly focusing on patients with primary immunodeficiency diseases.

PPTA News

EU Health Commissioner Says Plasma Donation is “More Important Than Ever” +

15 June, 2020 (Brussels) - The Plasma Protein Therapeutics Association (PPTA) welcomes EU Health Commissioner Kyriakides’ recognition of the importance of plasma donation in her observance yesterday of World Blood Donor Day. By noting plasma’s role in the manufacture of plasma-derived medicinal therapies (PDMPs) for people with a range of life-challenging diseases, as well as its potential role in treating people with COVID-19, Commissioner Kyriakides rightly notes that “donating plasma is therefore now more important than ever.”
Read More
New Edition of EDQM Blood Guide Risks Decreasing European Plasma Collection +

28 May 2020 (Brussels) - The Plasma Protein Therapeutics Association (PPTA) is concerned about the recommendations contained in 20th version of Blood Guide of The European Directorate for the Quality of Medicines (EDQM) which aims to harmonise standards and recommendations on blood collection, preparation, and the use of blood and blood components. This Guide, if applied, will have a negative impact on the availability of plasma to develop Plasma-Derived Medicinal Products (PDMPs) for European patients as it fails to distinguish between requirements for transfusable blood components and plasma for manufacturing, especially concerning donor deferrals.
Read More
Wall Street Journal: Letter to the Editor +

Dear Editor,

The article published May 3, “Researchers Explore Using Common Blood-Plasma Treatment to Fight Coronavirus,” calls necessary attention to the importance of intravenous immunoglobulin, IVIG, as a lifesaving therapy for people living with a range of serious, genetic, and chronic conditions. Increased use of IVIG as an untested treatment against COVID-19 risks limiting its availability for those patients whose lives rely on regular access to it. For many of these conditions, IVIG remains the only known treatment.
Read More
PPTA Encourages Plasma Donation +

President Trump made an appeal for plasma donation a few days ago and is echoing what people with serious, genetic, life-threatening diseases already know —plasma donors save lives! Most people had not given much thought to plasma before the recent COVID-19 pandemic. Now, they are learning that plasma from a patient who has recovered from COVID-19 could be used to make therapies to treat others who are sick with the disease and could eventually be used to safeguard health care workers.
Read More

› ‹

The Source, the international magazine of the plasma protein therapeutics industry, is published quarterly.

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Restrictive Coverage Policies and Patient Access

EU Health Commissioner Says Plasma Donation is “More Important Than Ever” +

New Edition of EDQM Blood Guide Risks Decreasing European Plasma Collection +

Wall Street Journal: Letter to the Editor +

PPTA Encourages Plasma Donation +

Media and Information

Advocacy